COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
02 2021
Historique:
received: 28 10 2020
revised: 31 12 2020
accepted: 18 01 2021
entrez: 6 2 2021
pubmed: 7 2 2021
medline: 20 2 2021
Statut: ppublish

Résumé

Although there are regional reports that the COVID-19 pandemic is associated with a reduction in acute myocardial infarction presentations and primary percutaneous coronary intervention (PCI) procedures, little is known about the impact of the COVID-19 pandemic on mechanical complications resulting from ST-segment elevation myocardial infarction (STEMI) and mortality. This single-centre retrospective cohort study analysed presentations, incidence of mechanical complications, and mortality in patients with STEMI before and after a state of emergency was declared due to the COVID-19 pandemic by the Japanese government on 7 April 2020. We analysed 359 patients with STEMI hospitalised before the declaration and 63 patients hospitalised after the declaration. The proportion of patients with late presentation was significantly higher after the declaration than before (25.4% vs 14.2%, p=0.03). The incidence of late presentation was significantly higher during the COVID-19 pandemic than before (incidence rate ratio (IRR), 2.41; 95% CI, 1.37 to 4.05; p=0.001, even after adjusting for month (IRR, 2.61; 95% CI, 1.33 to 5.13; p<0.01). Primary PCI was performed significantly less often after the declaration than before (68.3% vs 82.5%, p=0.009). The mechanical complication resulting from STEMI occurred in 13 of 359 (3.6%) patients before the declaration and 9 of 63 (14.3%) patients after the declaration (p<0.001). However, the incidence of in-hospital death (before, 6.2% vs after, 6.4%, p=0.95) was comparable. Following the COVID-19 pandemic, an increased incidence of mechanical complications resulting from STEMI was observed. Instructing people to stay at home, without effectively educating them to immediately seek medical attention when suffering symptoms of a heart attack, may worsen outcomes in patients with STEMI.

Identifiants

pubmed: 33547221
pii: openhrt-2020-001497
doi: 10.1136/openhrt-2020-001497
pmc: PMC7871043
pii:
doi:

Types de publication

Comparative Study Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Am Heart Assoc. 2014 Oct 20;3(5):e000984
pubmed: 25332178
Eur Heart J. 2018 Jan 14;39(3):201-208
pubmed: 29029233
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Eur Heart J. 2020 May 14;41(19):1852-1853
pubmed: 32297932
Circulation. 2013 Jan 29;127(4):e362-425
pubmed: 23247304
Epidemiology. 2009 Jul;20(4):488-95
pubmed: 19525685
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413
pubmed: 32791953
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Am J Cardiol. 2014 Dec 15;114(12):1789-93
pubmed: 25438903
JMIR Ment Health. 2020 Jun 1;7(6):e19347
pubmed: 32459186
Circulation. 2008 Dec 16;118(25):2783-9
pubmed: 19064683
N Engl J Med. 2007 Jan 4;356(1):47-54
pubmed: 17202455
Circ J. 2019 Apr 25;83(5):1085-1196
pubmed: 30930428
Heart. 2020 Dec;106(23):1805-1811
pubmed: 32868280
N Engl J Med. 2020 Aug 13;383(7):691-693
pubmed: 32427432
Am J Cardiol. 1995 Sep 15;76(8):543-7
pubmed: 7677073
Acta Med Scand. 1979;205(1-2):11-6
pubmed: 760397
Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2350-2355
pubmed: 29051141
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631

Auteurs

Satoshi Kitahara (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Masashi Fujino (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan fujinom@ncvc.go.jp.

Satoshi Honda (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Yasuhide Asaumi (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Yu Kataoka (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Fumiyuki Otsuka (F)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Michio Nakanishi (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Yoshio Tahara (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Soshiro Ogata (S)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Daisuke Onozuka (D)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Kunihiro Nishimura (K)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Tomoyuki Fujita (T)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Hisao Ogawa (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Teruo Noguchi (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH